clock.bio is a biotechnology company focused on aging and rejuvenation biology. It is building a platform to decode the rejuvenation genome and validate interventions that reverse cellular aging, with an initial emphasis on skin rejuvenation topicals and nutraceuticals to rapidly generate human data and measurable biology reversal. The company claims a three-pillar platform—geneAge Atlas of Aging and Rejuvenation, imAge for AI-driven biological age measurement, and clinAge for human validation—aiming to translate regenerative biology into healthspan-extending therapies across organs. It positions itself as a leader in rejuvenation biology, combining deep biology, AI, and translational clinical validation, with global scope and a mission to extend healthy lifespan by targeting upstream genetic programs.
No recent news for this company.
No recent deals for this company.